Bloomsbury Genetic Therapies secures £5M from UCL Technology Fund
13 October 2022
13 October 2022
Total investments received (USD): 5.64m
Company: Bloomsbury Genetic Therapies Limited
Industry:
Biotech
Health services
Related deals
Dxcover raised £7.5m
Investments
30 January 2023
NeoPhore in a £6M bridge funding round.
Investments
16 January 2023
Bactobio secured £6M in a financing round led by Bridford Group.
Investments
01 December 2022
Biorelate to raise £6.5M from Maven Capital and YFM
Investments
26 November 2022
Transine Therapeutics raised £4.6 million in additional seed funding from Epidarex Capital and the Dementia Discovery Fund.
Investments
12 May 2022
Netherlands
Austria
Switzerland
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Portugal
Spain